GenBody Rapid COVID-19 Ag Test
The GenBody COVID-19 Ag point-of-care test is a lateral flow chromatographic immunoassay intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus.
Variants (1)
- Default Title — 77.50 USD — In stock
AI Readiness
Good foundation, but some important product data is still missing.
72%